Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Preferred Dividend Payments (2022 - 2024)

Ensysce Biosciences (ENSC) has disclosed Preferred Dividend Payments for 3 consecutive years, with $290.0 as the latest value for Q1 2024.

  • On a quarterly basis, Preferred Dividend Payments fell 96.51% to $290.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $290.0, a 97.76% decrease, with the full-year FY2024 number at $290.0, down 97.76% from a year prior.
  • Preferred Dividend Payments was $290.0 for Q1 2024 at Ensysce Biosciences, down from $899.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $715579.0 in Q1 2022 to a low of $290.0 in Q1 2024.
  • A 3-year average of $115803.8 and a median of $19957.5 in 2022 define the central range for Preferred Dividend Payments.
  • Biggest YoY gain for Preferred Dividend Payments was 96.36% in 2023; the steepest drop was 98.84% in 2023.
  • Ensysce Biosciences' Preferred Dividend Payments stood at $31606.0 in 2022, then tumbled by 97.16% to $899.0 in 2023, then tumbled by 67.74% to $290.0 in 2024.
  • Per Business Quant, the three most recent readings for ENSC's Preferred Dividend Payments are $290.0 (Q1 2024), $899.0 (Q4 2023), and $3729.0 (Q2 2023).